Study of Piclidenoson for Lowe Syndrome in adult males
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests an oral drug called Piclidenoson to see if it is safe and effective for men with Lowe Syndrome. It may help improve kidney function and other symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male aged 18 or older.
- You have a genetic diagnosis of Lowe Syndrome.
- Your kidney function (eGFR) is at least 40 mL/min.
- You agree to use condoms and not donate sperm during the trial and for 1 month after.
- You are able to follow the study plan and give consent (your guardian can too).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with certain rare kidney conditions that can cause kidney stones. It aims to learn how these conditions behave over time and may help improve future care.
This trial tests an oral medication called piclidenoson for people with moderate-to-severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms.
This trial tests a new drug called QLS1410. It is given once to healthy volunteers and to people with mild high blood pressure to see how the body handles it and if it lowers blood pressure safely.
This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.
This study tests a new drug called LBL-047 in healthy people and in people with mild to moderate lupus. It helps check if the drug is safe and how the body processes it. Participating may help find better treatments for lupus.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
Hear when a new Lowe Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.